Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens(Leipzig University), Benjamin Weide(University Children's Hospital Tübingen)
Cited by 541
Related Papers
Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
|Clinical Cancer Research|2016|583
Predictors of responses to immune checkpoint blockade in advanced melanoma
|Nature Communications|2017|201
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic Melanoma
|JCO Precision Oncology|2019|54
ctDNA as a noninvasive monitoring tool in metastatic melanoma.
|Journal of Clinical Oncology|2019|0